simply interpreted to indicate that the virus is involved in the disease process. In this context, we have several points which we would like to raise regarding the study of Rymbai et al. It is well-established that EBV is aetiologically associated with the pathogenesis of approximately 10% of GC. [4] In these cases, the virus can be detected in the malignant cells of GC by Epstein-Barr encoded RNA (EBER) in situ hybridisation or Epstein-Barr nuclear antigen 1 (EBNA-1) immunohistochemistry. Rymbai et al. reported an association between EBV and GC based on the detection of EBNA-1 mRNA using real-time PCR (RT-PCR). We find this to be an insufficient approach to conclude a virus-disease association, bearing in mind that EBV is ubiquitous in the healthy population. Furthermore, the detection of EBNA-1 mRNA does not necessarily mean that the corresponding protein is expressed at the translational level, and it certainly does not indicate which cells within the tumour are expressing it. The authors reported 6% (6/100) of their cases to be positive for EBNA-1 mRNA. In 2 of the 6 positive cases, EBNA-1 mRNA was also detected in non-tumour tissues. It is impossible to know if the cellular source of EBNA-1 mRNA in these 2 cases was malignant cells which had metastasised from the main tumour or non-malignant tumour infiltrating lymphocytes which happened to be EBV positive. [5] This could have easily been resolved by performing EBNA-1 immunohistochemistry instead of RT-PCR. Alternatively, the authors could have examined their cases for the presence of EBV using EBER in situ hybridisation. This highly sensitive and specific method is widely used as the gold standard for the detection of EBV in histological tissues. This approach would have given a much better indication of the true proportion of EBV-associated GC cases in the Indian population.
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There are no conflicts of interest. infections in this group. After obtaining informed consent, questionnaire was administered to the participants. Five millilitre of blood was drawn aseptically from the participants and tested for HBs antigen, and antibodies for HCV, HIV-1 and HIV-2. We studied total 80 SKs. None had received hepatitis B vaccination in the past. History of unintentional injury with sharps or needles during work was reported by 55 (68.7%). Multiple encounters were reported by 36 (45%). Though all of them washed the injured body part with water, only few used soap to clean the part. Consultation with a doctor was sought by only 7 (12%). Most of them that is, 74 (92%) were not even aware of any post exposure prophylaxis (PEP) that can be had to prevent diseases after sharps injuries. They also showed ignorance about whom to approach for consultation after the injury.
Awareness about needlestick harms and health seeking behaviour among the Safai Karamcharis at Dr. Rajendra Prasad Government Medical College Kangra at Tanda (Himachal Pradesh)
Thirty-eight (47.5%) of them had been tested for HIV, HCV, and HBsAg earlier for some other study and were all found to be non-reactive (unpublished data). Awareness regarding HIV, HBV, and HCV as a disease acquired by sharps injury was reported by 47.5%, 5%, and 0% respectively.
Only 1 member of the study group was reactive for HBs Antigen, and none were reactive for HIV-1, HIV-2 or HCV. Our state falls under low endemicity for HIV, HBV, and HCV, which may have been the reason for the low prevalence of these infections in our study group despite frequent sharps injuries they receive.
The study was done to check the prevalence of infections and needle pricks. Based on the results of this study, we counselled the SKs to get vaccinated against hepatitis B and to consult the medical officer in casualty regarding the need of PEP against HIV whenever they get a needlestick injury again.
The same group was followed after 2 years to see the effects of the earlier study. We found that 9 SKs had taken 1-month PEP after consulting the doctors in last 2 years. Five of them were females and 8 had a needle prick while one had injury by a surgical blade. Four of them were classified as moderate exposure while 5 were mild exposures. The source was unknown in all and all were given basic regimen for 1-month. To our surprise, none of them had got vaccinated for hepatitis B. So, we counselled them again and the main reason we found was their reluctance to pay from their own pockets for the vaccine. This time we were able to initiate the process of hepatitis B vaccination as the vaccine was available in the hospital supply.
